09:00 AM EDT, 09/09/2024 (MT Newswires) -- US equity futures posted gains ahead of Monday's opening bell, rebounding from losses in the previous session fueled by a weaker-than-expected monthly jobs report.

The Dow Jones Industrial Average futures rose 0.6%, S&P 500 futures increased 0.6% and Nasdaq futures were up 0.7%.

The Bureau of Labor Statistics reported Friday nonfarm payrolls of 142,000 in August, lower than estimates compiled by Bloomberg for a 165,000 jobs growth.

Oil prices were higher, with front-month global benchmarks North Sea Brent crude up 0.8% at $71.67 per barrel and West Texas Intermediate crude up 1.1% at $68.33 per barrel.

In other world markets, Japan's Nikkei closed 0.5% lower, Hong Kong's Hang Seng ended 1.4% lower, and China's Shanghai Composite finished 1.1% lower. Meanwhile, the UK's FTSE 100 rose 0.6% and Germany's DAX index gained 0.4% in Europe's early afternoon session.

In equities, shares of Summit Therapeutics ( SMMT ) were up 30% after the company reported that a phase 3 trial of ivonescimab demonstrated significantly improved progression-free survival in patients with non-small cell lung cancer. Terns Pharmaceuticals ( TERN ) shares increased 19% after reporting that a phase 1 trial of its obesity drug demonstrated a statistically significant mean weight loss of up to 5.5%.